Welcome to MedPharm Publications

THE IMPORTANCE OF A PLATELET-ACTIVATING FACTOR (PAF) ANTAGONIST IN ALLERGY TREATMENT

Platelet-activating factor (PAF) is today considered an important mediator in allergic and inflammatory reactions. While histamine is the primary mediator involved in the pathophysiology of Allergic Rhinitis and chronic Urticaria, it is clearly not the only mediator involved in the inflammatory process. Histamine and platelet-activating factor (PAF) both play an important role in Allergic Rhinitis.

New review of clinical studies shows that antidepressants are effective, but must be given a chance to work

New review of clinical studies shows that antidepressants are effective, but must be given a chance to work Depression affects millions of people worldwide.1 ref 1A It can be severely disabling, impacting general health and wellbeing, and performance at work and...

The Science is in the Sample – provided it is Representative

Current sampling practice is a result of the combination of statistics with scientific knowledge about the product/material being sampled.  Such knowledge is acquired through experimentation and the use of various sampling techniques until reproducible results, from representative samples, can be obtained. 

NEW LEADERSHIP AT THE HELM OF GENERICS AND BIOSIMILAR MEDICINES ASSOCIATION

Generic and Biosimilar Medicines of Southern Africa (GBMSA), formerly known as the National Association of Pharmaceutical Manufacturers (NAPM), has appointed Erik Roos, CEO of Pharma Dynamics as Vice Chairperson to support the existing Chairperson, Lorraine Keyser, CEO of Dr Reddy’s, as of June 2018.

One year on – Novartis, DST and SAMRC MoU builds scientific capability in South Africa

One year after the signing of a Memorandum of Understanding (MoU) between Novartis, the South African Department of Science and Technology (DST) and South African Medical Research Council (SAMRC), Novartis reports that the collaboration is revealing significant latent potential for scientific discovery in South Africa.

Medpharm Publications was founded in 1988 and has established itself as the largest medical and pharmaceutical journal publisher in South Africa.
With a publications list of more than ten titles comprising of over fifty journal editions, Medpharm Publications reach more than 40 000 healthcare workers countrywide with printed editions, and has established a global audience with the online editions.
The majority of Medpharm Publications’ journals are associated with professional or scholarly societies and acts as the official South African mouthpiece in the associated discipline. All journals are web-based, most of which are fully peer-reviewed, with five titles accredited by the South African Department of Higher Education and Training (DHET) to earn research subsidies for academic departments.
As a publisher, passionate about journal publishing, we believe that South African researchers and clinicians can and will make a significant contribution to world medical literature.